Critical accounting estimates and judgements (Details) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| MTX228 tolimidone acquired IPRD* [member] | |||||
| IfrsStatementLineItems [Line Items] | |||||
| % change in fair value | [1] | 40.00% | 41.00% | 18.00% | |
| MTX230 eRapa acquired IPRD* [member] | |||||
| IfrsStatementLineItems [Line Items] | |||||
| % change in fair value | [1] | 20.00% | 19.00% | ||
| |||||